Abhimanyu Garg: Dyslipidemias | Taschenbuch

Cover: 9781493958528 | Dyslipidemias | Pathophysiology, Evaluation and Management | Garg

Dekorationsartikel gehören nicht zum Leistungsumfang.

Sprache: Englisch

139,09 €*

inkl. MwSt.

Versandkostenfrei per Post / DHL

Aktuell nicht verfügbar

Kategorien:

Der Artikel ist nicht in deutscher Sprache verfasst.
Die Sprache der Produktbeschreibung und Details kann in Englisch angegeben sein. Sollten Sie Verständnisprobleme haben, wenden Sie sich gerne an uns.

Beschreibung

Dyslipidemias: Pathophysiology, Evaluation and Management provides a wealth of general and detailed guidelines for the clinical evaluation and management of lipid disorders in adults and children. Covering the full range of common through rare lipid disorders, this timely resource offers targeted, practical information for all clinicians who care for patients with dyslipidemias, including general internists, pediatric and adult endocrinologists, pediatricians, lipidologists, cardiologists, internists, and geneticists. For the last twenty years, there has been a growing recognition worldwide of the importance of managing dyslipidemia for the primary and secondary prevention of atherosclerotic vascular disease, especially coronary heart disease. This has been mainly due to the publication of the guidelines of National Cholesterol Education Program¿s Adult Treatment Panel and Pediatric Panel from the United States. These guidelines have stimulated generation of similar recommendations from all over the world, particularly Europe, Canada, Australia and Asia. Developed by a renowned group of leading international experts, the book offers state-of-the-art chapters that are peer-reviewed and represent a comprehensive assessment of the field. A major addition to the literature, Dyslipidemias: Pathophysiology, Evaluation and Management is a gold-standard level reference for all clinicians who are challenged to provide the best care and new opportunities for patients with dyslipidemias.

Über den Autor

Abhimanyu Garg, MBBS, MD

Professor of Internal Medicine

UT Southwestern Medical Center

Department of Internal Medicine

5323 Harry Hines Blvd

Dallas, TX 75390

TEL 214-648-2895

Zusammenfassung

State-of-the-art, comprehensive title

Broad, up-to-date overview coupled with detailed guidelines for the clinical evaluation and management of lipid disorders in adults and children

Covers full range of common though rare lipid disorders

Offers targeted, practical information for all clinicians

Developed by leading international experts

Includes supplementary material: [...]

Inhaltsverzeichnis

Chapter 1. Lipoprotein Physiology Chapter 2. Epidemiology of Blood Lipids and Lipoproteins Chapter 3. Lipoprotein(a) Chapter 4. Lipoproteins and Cardiovascular Disease Risk Chapter 5. Detection and Treatment of Children and Adolescents with Dyslipidemia Chapter 6. Type 2 Diabetes Mellitus and Dyslipidemia Chapter 7. Type 1 Diabetes Mellitus and Dyslipidemia Chapter 8. Dyslipidemia in Chronic Kidney Disease and Nephrotic Syndrome Chapter 9. Dyslipidemia in HIV-infected PatientsChapter 10. Monogenic Hypercholesterolemia Chapter 11. Primary Hypertriglyceridemia Chapter 12. Genetic Disorders of HDL Metabolism Chapter 13. Sitosterolemia and Other Rare Sterol Disorders Chapter 14. Genetic Abetalipoproteinemia & Hypobetalipoproteinemia Chapter 15. Drug-induced Dyslipidemia Chapter 16. Lipodystrophies and Dyslipidemias Chapter 17. Novel Genes for Dyslipidemias: Genome-Wide Association Studies Chapter 18. Perspectives on Cholesterol GuidelinesChapter 19. Nutrition and Coronary Heart Disease Prevention Chapter 20. Phytosterol Therapy Chapter 21. N-3 Fatty Acids: Role in Treating Dyslipidemias and Preventing Cardiovascular Disease Chapter 22. Polyphenols for Cholesterol Management Chapter 23 - Dietary Supplements for Cholesterol ManagementChapter 24. Statins: Risk-Benefits and Role in Treating Dyslipidemias Chapter 25. Fibrates: Risk-Benefits and Role in Treating Dyslipidemias Chapter 26. Niacin: Risk-Benefits and Role in Treating Dyslipidemias Chapter 27. Bile Acid Sequestrants: Risk-Benefits and Role in Treating DyslipidemiasChapter 28. Cholesterol Absorption Inhibitor-Ezetimibe: Risk-Benefits and Role in Treating Dyslipidemias Chapter 29. Low Density Lipoprotein (LDL) ApheresisChapter 30. Novel Lipid Lowering Agents

Details

Erscheinungsjahr:	2016
Fachbereich:	Andere Fachgebiete
Genre:	Medizin
Rubrik:	Wissenschaften
Medium:	Taschenbuch
Reihe:	Contemporary Endocrinology
Inhalt:	xvi 525 S. 26 s/w Illustr. 101 farbige Illustr. 525 p. 127 illus. 101 illus. in color.
ISBN-13:	9781493958528
ISBN-10:	1493958526
Sprache:	Englisch
Ausstattung / Beilage:	Paperback
Einband:	Kartoniert / Broschiert
Redaktion:	Garg, Abhimanyu
Herausgeber:	Abhimanyu Garg
Auflage:	Softcover reprint of the original 1st ed. 2015
Hersteller:	Humana Press Humana Press Inc. Contemporary Endocrinology
Maße:	254 x 178 x 30 mm
Von/Mit:	Abhimanyu Garg
Erscheinungsdatum:	12.10.2016
Gewicht:	1,011 kg

Artikel-ID: 102997565